Keyphrases
Ataxia Telangiectasia
100%
Immunodeficiency
100%
Malignancy
18%
Hypogammaglobulinemia
18%
Hyper IgM
18%
High Risk
9%
Ataxia Telangiectasia mutated
9%
Confidence Interval
9%
Respiratory Disease
9%
Poor Prognosis
9%
Retrospective Cohort Study
9%
Treatment Trials
9%
Therapeutic Trial
9%
Neurodegenerative Diseases
9%
Life Expectancy
9%
Risk of Malignancy
9%
Counsel
9%
Risk Treatment
9%
IgG2
9%
Follow-up Program
9%
HR Hazard Ratio
9%
OR Odds Ratio
9%
IgG2 Deficiency
9%
Medicine and Dentistry
Immune Deficiency
100%
Ataxia Telangiectasia
100%
Cancer
25%
Immunoglobulin M
16%
Hypogammaglobulinemia
16%
Combination Therapy
8%
Odds Ratio
8%
Hazard Ratio
8%
Respiratory Disease
8%
Retrospective Cohort Study
8%
Life Expectancy
8%
Neurodegenerative Disorder
8%
Immunoglobulin G Deficiency
8%
Immunoglobulin G2
8%
Nursing and Health Professions
Ataxia Telangiectasia
100%
Immune Deficiency
100%
Immunoglobulin M
16%
Immunoglobulin Deficiency
16%
Odds Ratio
8%
Hazard Ratio
8%
Confidence Interval
8%
Combination Therapy
8%
Cohort Analysis
8%
Respiratory Tract Disease
8%
Nomenclature
8%
Life Expectancy
8%
Immunoglobulin G Deficiency
8%
Immunoglobulin G2
8%
Diseases
8%
Pharmacology, Toxicology and Pharmaceutical Science
Ataxia Telangiectasia
100%
Immune Deficiency
100%
Immunoglobulin M
16%
Immunoglobulin Deficiency
16%
Cohort Study
8%
Combination Therapy
8%
Respiratory Tract Disease
8%
Life Expectancy
8%
Immunoglobulin G2
8%
Immunoglobulin G Deficiency
8%
Diseases
8%
Immunology and Microbiology
Immunodeficiency
100%
Ataxia Telangiectasia
100%
Immunoglobulin M
16%
Hypogammaglobulinemia
16%
Life Expectancy
8%
Nomenclature
8%
Immunoglobulin G2
8%
IgG Deficiency
8%
Neuroscience
Ataxia Telangiectasia
100%
Immunoglobulin M
18%
Immunoglobulin G2
18%
Ataxia Telangiectasia Mutated
9%
Respiratory Diseases
9%
Neurodegenerative Disorder
9%